- •Foreword
- •Preface
- •Contents
- •Contributors
- •Acronyms
- •1.1 Introduction
- •1.2 Epidemiology
- •1.3 Risk Factors
- •1.3.1 Duration of Diabetes Mellitus
- •1.3.2 Glycemic Control
- •1.3.3 Hypertension
- •1.3.4 Ethnic Differences
- •1.3.5 Obesity
- •1.3.6 Socioeconomic Status
- •1.3.7 Other Risk Factors
- •1.4 Pathophysiology
- •Conclusion
- •References
- •2: Non-proliferative Diabetic Retinopathy
- •2.1 Clinical Overview
- •2.1.1 Clinical Findings
- •2.1.2 Classification of NPDR
- •2.1.3 Atypical Forms of NPDR
- •2.2 Diagnostic Tools
- •2.2.1 Telemedicine
- •2.2.2 Fundus Photography
- •2.2.3 Fluorescein Angiography
- •2.2.4 Ultrasonography
- •2.2.5 Optical Coherence Tomography
- •2.2.6 Adaptive Optics Scanning Laser Ophthalmoscope
- •2.2.7 Multifocal Electroretinogram
- •2.2.8 Pattern Visual Evoked Potentials
- •2.2.9 Other Diagnostic Tools
- •2.3 Present Therapies
- •2.3.1 Primary Interventions
- •2.3.1.1 Glycemic Control
- •2.3.1.2 Blood Pressure Control
- •2.3.1.3 Lipid-Lowering Therapy
- •2.3.2 Secondary Interventions
- •2.3.2.1 Protein Kinase C Inhibitors
- •2.4 Evolving Algorithms
- •2.4.1 Screening
- •2.4.2 Laser Photocoagulation
- •2.5 New Frontiers
- •References
- •3: Diabetic Macular Edema
- •3.1 Clinical Overview
- •3.1.1 Clinical Findings
- •3.1.2 Biomicroscopic Classification of DME
- •3.2 Diagnostic Tools
- •3.2.1 Fluorescein Angiography
- •3.2.2 Optical Coherence Tomography
- •3.2.3 Fundus Photography
- •3.2.4 Microperimetry
- •3.2.5 Multifocal Electroretinogram
- •3.2.6 Other Imaging Under Investigation
- •3.3 Present Therapies
- •3.3.1 Laser Photocoagulation
- •3.3.2 Intravitreal Pharmacotherapies
- •3.3.2.1 Intravitreal Steroids
- •3.3.2.2 Intravitreal Anti-VEGF
- •3.3.3 Pars Plana Vitrectomy
- •3.4 Evolving Algorithms
- •3.4.1 Therapeutic Algorithms
- •3.4.2 Factors Associated with Favorable Response to the Therapy
- •3.4.3 Treatment of DME Associated with Macular Ischemia
- •3.5 New Frontiers
- •References
- •4: Proliferative Diabetic Retinopathy
- •4.1 Clinical Overview
- •4.1.1 Clinical Findings
- •4.1.2 Classification of PDR
- •4.2 Diagnostic Tools
- •4.2.1 Fluorescein Angiography
- •4.2.2 Fundus Photography
- •4.2.3 Ultrasonography
- •4.2.4 Optical Coherence Tomography
- •4.2.5 Perimetry
- •4.2.6 Further Diagnostic Tools
- •4.3 Present Therapies
- •4.3.1 Panretinal Laser Photocoagulation
- •4.3.2 Intravitreal Injections
- •4.3.2.1 Intravitreal Steroids
- •4.3.2.2 Intravitreal Anti-VEGF Agents
- •4.4 Evolving Algorithms
- •4.5 New Frontiers
- •References
- •5.1 Introduction
- •5.2 Pathophysiology
- •5.3 Neovascular Glaucoma
- •5.4 Tractional Retinal Detachment
- •5.5 Treatment
- •5.5.1 Panretinal Laser Photocoagulation
- •5.5.2 Pars Plana Vitrectomy and Endophotocoagulation
- •5.5.4 Silicone Oil Tamponade
- •5.5.4.1 Viscodissection
- •Conclusion
- •References
Clinical Strategies in
the Management of
Diabetic Retinopathy
A step-by-step Guide for Ophthalmologists
Francesco Bandello
Marco Attilio Zarbin
Rosangela Lattanzio
Ilaria Zucchiatti
Editors
Clinical Strategies in the Management
of Diabetic Retinopathy
Francesco Bandello • Marco Attilio Zarbin
Rosangela Lattanzio • Ilaria Zucchiatti
Editors
Clinical Strategies in the
Management of Diabetic
Retinopathy
A step-by-step Guide for Ophthalmologists
Editors |
|
Francesco Bandello |
Rosangela Lattanzio |
Department of Ophthalmology |
Department of Ophthalmology |
University Vita-Salute |
University Vita-Salute |
Scientific Institute San Raffaele |
Scientific Institute San Raffaele |
Milano |
Milan |
Italy |
Italy |
Marco Attilio Zarbin |
Ilaria Zucchiatti |
Department of Ophthalmology |
Department of Ophthalmology |
Rutgers University |
University Vita-Salute |
Newark, NJ |
Scientific Institute San Raffaele |
USA |
Milan |
|
Italy |
ISBN 978-3-642-54502-3 ISBN 978-3-642-54503-0 (eBook)
DOI 10.1007/978-3-642-54503-0
Springer Heidelberg New York Dordrecht London
Library of Congress Control Number: 2014937911
© Springer-Verlag Berlin Heidelberg 2014
This work is subject to copyright. All rights are reserved by the Publisher, whether the whole or part of the material is concerned, specifically the rights of translation, reprinting, reuse of illustrations, recitation, broadcasting, reproduction on microfilms or in any other physical way, and transmission or information storage and retrieval, electronic adaptation, computer software, or by similar or dissimilar methodology now known or hereafter developed. Exempted from this legal reservation are brief excerpts in connection with reviews or scholarly analysis or material supplied specifically for the purpose of being entered and executed on a computer system, for exclusive use by the purchaser of the work. Duplication of this publication or parts thereof is permitted only under the provisions of the Copyright Law of the Publisher's location, in its current version, and permission for use must always be obtained from Springer. Permissions for use may be obtained through RightsLink at the Copyright Clearance Center. Violations are liable to prosecution under the respective Copyright Law.
The use of general descriptive names, registered names, trademarks, service marks, etc. in this publication does not imply, even in the absence of a specific statement, that such names are exempt from the relevant protective laws and regulations and therefore free for general use.
While the advice and information in this book are believed to be true and accurate at the date of publication, neither the authors nor the editors nor the publisher can accept any legal responsibility for any errors or omissions that may be made. The publisher makes no warranty, express or implied, with respect to the material contained herein.
Printed on acid-free paper
Springer is part of Springer Science+Business Media (www.springer.com)
This book is dedicated to Professor Rosario Brancato who was a Master and a Pioneer in the field of Diabetic Retinopathy diagnosis and treatment.
Foreword
A new era in the management of diabetic retinopathy has started, offering for the first time recovery of visual acuity compared to previous treatments, such as laser photocoagulation which aimed at disease stabilization. However, in this new environment of recently approved treatments and new promising therapeutic strategies, clinicians are faced with difficult decisions to choose the appropriate practice in each individual case.
The purpose of this practical guide is to assist ophthalmologists in making decisions in the management of diabetic retinopathy. This richly illustrated manual is based on the best evidence available and provides the practical and complete recommendations to guide clinicians in the management of diabetic retinopathy, including diagnosis, decision-making, and treatment.
This book is designed to address all the different and complex stages of diabetic retinopathy starting from the early stages up to the more advanced and sightthreatening levels of the disease. The publication provides also new insights in the management and surgical approach of diabetic retinopathy, providing the more updated techniques to fight this serious eye disease.
The chapters of this manual are enriched by practical tables and easy-to-read summaries that explain the progression of the disease and help the clinician to choose the best therapeutic approach. Moreover, the manual is enriched by algorithms that describe the suggested treatment approach, helping ophthalmologists in the difficult task of making treatment decisions.
The text is supplemented by almost one hundred illustrations, which contain in some of the cases a further follow-up. Several clinical cases are presented through multipart figures that represent the evolution from baseline to final follow-up of the clinical features of the eyes that have been treated with the more recently introduced drugs and surgeries. The case reports run in parallel with the text, showing practical examples of the effects of the treatment described in the text.
Clinical strategies in the management of diabetic retinopathy examine all stages of diabetic retinopathy to provide the latest developments in diagnosis and treatment of this severe disease.
I believe that this contribution is timely and will be appreciated by anyone that is faced on a day-to-day basis with the management of diabetic patients with retinal disease.
Coimbra, Portugal |
José Cunha-Vaz |
vii
Preface
Diabetic retinopathy remains the leading cause of visual impairment among the working-age population. There is evidence that visual loss could be reduced substantially by strict glycometabolic and effective blood pressure control. Nevertheless, diabetic macular edema and proliferative diabetic retinopathy currently remain the more dramatic and sight-threatening complications, which need a prompt and effective treatment.
For nearly a half century, focal laser photocoagulation was the only scientifically proven effective treatment to prevent visual loss due to diabetic macular edema. Recently, new intravitreal agents, such as anti-vascular endothelium growth factor agents and steroids, have been introduced in the management of the disease. The main advantage of the intravitreal injections compared to focal laser photocoagulation is the chance not only to prevent visual decline but also to promote visual recovery. In addition, combination therapy involving intravitreal injection and laser photocoagulation recently has been considered a promising strategy to improve the results further. In some cases of diabetic macular edema and advanced proliferative diabetic retinopathy, surgical intervention with pars plana vitrectomy and membrane peeling remains the mainstay of treatment.
Considerable evidence now shows that prompt treatment is necessary to prevent the visual impairment from non-proliferative as well as from proliferative diabetic retinopathy. However, the introduction of several treatment strategies has created the need for new worldwide guidelines to manage all the stages of diabetic retinopathy.
This book derives from two different schools, the European and the American groups, which are geographically distant from each other, but share the same approach and methodology in the management of this complex disease, diabetic retinopathy, resulting from evidence-based medicine and from randomized clinical trials.
This clinical manual covers all the stages of diabetic retinopathy, including clinical manifestations, imaging, and treatment, from the early signs to the more advanced levels of severity. This guide is designed to present to the reader multiple practical and useful suggestions for the management of each stage of diabetic retinopathy, using algorithms, tables, and summaries.
ix
x |
Preface |
|
|
Images of sample cases help the reader to deepen his or her understanding of the effects of the different therapies, including benefits and side effects. Novel perspectives in the imaging and treatment are described clearly in order to show where current research in the field is focused.
Milan, Italy |
Francesco Bandello, MD, FEBO |
Newark, NJ, USA |
Marco Attilio Zarbin, MD, PhD |
Milan, Italy |
Rosangela Lattanzio, MD |
Milan, Italy |
Ilaria Zucchiatti, MD |
